Literature DB >> 28406121

Normalization of the psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in Turkey.

Bdo Coskun1, M Ozen2, S Gursoy3, O Ozbakir3, O K Poyrazoglu1, M Baskol3, G C Sezgin3, M Yucesoy3.   

Abstract

AIM: To construct normal values for the tests of the psychometric hepatic encephalopathy score (PHES) and evaluate the prevalence of minimal hepatic encephalopathy (MHE) among Turkish patients with liver cirrhosis.
MATERIALS AND METHODS: One hundred and eighty-five healthy subjects and sixty patients with liver cirrhosis without overt hepatic encephalopathy were included in the study. All subjects underwent psychometric tests, which include number connection test-A and B (NCT-A/B), serial dotting test (DST), line drawing test (LDT), and digit symbol test (DST) in the same day. The variables that affected the results of the test were included in the multiple linear regression models and formulas were constructed to predict the expected results for each tests.
RESULTS: The results of all PHES tests, except the LDT in the cirrhotic group were significantly different than center of gravity (CG) (P < 0,001). The score of PHES in the cirrhotic group was -2,18 ± 3,3 (median -2; range: 11 to +4), significantly lower than CG (-0.31 ± 2.18 [median, 0; range, -8 to +5]) (P < 0.001). the cutoff of PHES was set -4 point. Therefore, 19 of the 60 cirrhotic patients were diagnosed with MHE (31.6%). Among the patients with MHE, 11 (11/45, 24,4%) had Child-Pugh classification (CTP) A and 8 (8/15, 53.3%) had CTP B. No differences in age and education years were found between the MHE and non-MHE groups (P > 0.05).
CONCLUSION: Turkish PHES normograms have been developed for detecting patients with MHE. Future multicenter national studies are needed to validate widely applicable norms.

Entities:  

Mesh:

Year:  2017        PMID: 28406121     DOI: 10.4103/1119-3077.204375

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  5 in total

Review 1.  Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.

Authors:  Ming Luo; Ping Ma; Lei Li; Wu-Kui Cao
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

Review 2.  Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Weijia Han; Huanqian Zhang; Ying Han; Zhongping Duan
Journal:  Metab Brain Dis       Date:  2020-06-03       Impact factor: 3.584

3.  The Prevalence and Association of Cognitive Impairment with Sleep Disturbances in Patients with Chronic Liver Disease.

Authors:  Oana-Mihaela Plotogea; Camelia Cristina Diaconu; Gina Gheorghe; Madalina Stan-Ilie; Mircea-Alexandru Badea; Cristina Cijevschi Prelipcean; Gabriel Constantinescu
Journal:  Brain Sci       Date:  2022-03-26

Review 4.  Recent advances in hepatic encephalopathy.

Authors:  Victoria Liere; Gurkarminder Sandhu; Sharon DeMorrow
Journal:  F1000Res       Date:  2017-09-04

5.  Normalisation of the psychometric encephalopathy score within the Cameroonian population.

Authors:  Larissa Pessidjo Djomatcho; Mathurin Pierre Kowo; Antonin Ndjitoyap Ndam; Sylvain Raoul Simeni Njonnou; Gabin Ulrich Kenfack; Firmin Ankouane Andoulo; Servais Fiacre Eloumou Bagnaka; Winnie Tatiana Bekolo; Agnès Malongue; Isabelle Dang Babagna; Magloire Biwolé Sida; Henry Luma; Oudou Njoya
Journal:  BMC Gastroenterol       Date:  2021-07-12       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.